European Pharmaceutical Manufacturer explores the rise of ketamine as treatment for depression and why a recent study shines hope on the drug being used to treat alcohol use disorder.
Ian Bolland is joined by Martin Gouldstone and Ray Valencia from Sensyne Health to explain more about the use of synthetic control arms, clinical trial transformation, speeding up the process and its SENSIGHT platform – which works within the NHS.
Ashley Fraser and Clara Zacharko, CRA Life Sciences Practice, Toronto look at what revised guidelines to the Patented Medicine Prices Review Board means for drug pricing in Canada.
We speak to professor Janet Hemingway, the founding director of the Infection Innovation Consortium (iiCON) to find out all about the work the organisation has done throughout the Covid-19 pandemic.
Dr Toby Astill, global market manager - Cannabis and Hemp Markets at PerkinElmer, talks about the growth of cannabis in the pharmaceutical industry and the importance of chromatography to this sector.
Gary Connors, partner at Oliver Wight looks at why the pharmaceutical sector is lagging behind other sectors in removing plastic from their products and processes?
